Bio-Techne (TECH) Capital Expenditures (2009 - 2026)

Bio-Techne's Capital Expenditures history runs 18 years deep, the most recent figure standing at $9.1 million for Q1 2026.

• In Q1 2026, Capital Expenditures fell 10.24% year-over-year to $9.1 million; the TTM figure through Mar 2026 stood at $25.3 million (down 42.72% YoY), while the FY2025 annual figure was $31.0 million, down 50.69% from the prior year.
• Capital Expenditures for Q1 2026 stood at $9.1 million, up from $5.9 million in the prior quarter.
• The five-year high for Capital Expenditures was $18.0 million in Q2 2024, with the low at $4.9 million in Q2 2025.
• The 5-year median for Capital Expenditures is $10.1 million (2025), against an average of $10.7 million.
• The sharpest annual moves came in 2023 and 2025: Capital Expenditures surged 143.31% in 2023, then slumped 72.8% in 2025.
• Bio-Techne's Capital Expenditures stood at $6.1 million in 2022, then jumped by 143.31% to $14.9 million in 2023, then plunged by 54.11% to $6.8 million in 2024, then decreased by 13.19% to $5.9 million in 2025, then jumped by 53.45% to $9.1 million in 2026.
• Business Quant data shows TECH's Capital Expenditures at $9.1 million in Q1 2026, $5.9 million in Q4 2025, and $5.4 million in Q3 2025.